BioFinland Member

DelSiTech is an innovative drug delivery technology company that helps its customers to turn their active agents into novel and useful therapeutic drug products. DelSiTech also develops its own in-house supergeneric drug products to address significant unmet medical and commercial needs.

Delivery technology based on proprietary biodegradable silica matrix
Suitable for small molecules, proteins, carbohydrates, RNA, DNA, and viral vectors
Drug release time adjustable from few days to several months
Injectable and implantable dosage forms
Routes of administration: subcutaneous, intramuscular, topical, intravitreal
Special applications for ophthalmic dosing and veterinary applications